Yoji Nagasaki

2.8k citations
31 papers · 349 indexed · h-index 10
Topics
Antifungal resistance and susceptibility (8 papers)Fungal Infections and Studies (6 papers)COVID-19 Clinical Research Studies (5 papers)

In The Last Decade

Yoji Nagasaki

26 papers receiving 344 citations

Peers

Yoji Nagasaki
Comparison fields: 5 of 66
  • Infectious Diseases 242
  • Epidemiology 190
  • Molecular Medicine 40
  • Molecular Biology 36
  • Pharmacology 35
Replace Christopher A. Kerantzas with:
Christopher A. Kerantzas United States
Marisa Zenaide Ribeiro Gomes Brazil
Onur Kaya Türkiye
Márcia Halpern Brazil
Mamiko Niki Japan
Anshika Narang India
Agnieszka Broda United Kingdom
Giuseppina De Sio Italy
Maria Daniela Bergamasco Brazil
Demetrios G. Halkias United States
Yoji Nagasaki relative to Christopher A. Kerantzas United States Christopher A. Kerantzas's profile →
Citations per field
00.5×1.5×2.1×
Christopher A. Kerantzas · 1×
Citations per year

Countries citing papers authored by Yoji Nagasaki

Since Specialization
Citations

This map shows the geographic impact of Yoji Nagasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoji Nagasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoji Nagasaki more than expected).

Fields of papers citing papers by Yoji Nagasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoji Nagasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoji Nagasaki. The network helps show where Yoji Nagasaki may publish in the future.

Co-authorship network of co-authors of Yoji Nagasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yoji Nagasaki. A scholar is included among the top collaborators of Yoji Nagasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoji Nagasaki. Yoji Nagasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 5
5 0
6 4
7 5
8 9
9 3
10 26
11 79
12 11
13
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
3
14
Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
0
15 25
16 17
17 13
18 2
19 4
20 6

About Yoji Nagasaki

Yoji Nagasaki is a scholar working on Microbiology, Infectious Diseases and Clinical Biochemistry, having authored 31 papers that have together received 349 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (8 papers), Fungal Infections and Studies (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Infectious Diseases (242 citations), Molecular Medicine (40 citations) and Epidemiology (190 citations). Yoji Nagasaki has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Yanan Zhao, David S. Perlin, Cornelius J. Clancy, Nobuyuki Shimono, Milena Kordalewska, Brendan Prideaux, Landry Blanc, Pei‐Yu Chen, Matthew Zimmerman and Véronique Dartois. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026